During the past decade, Woodland International Research Group conducted 76 clinical trials. In the 10-year time frame, 76 clinical trials started and 47 clinical trials were completed, i.e. on average, 61.8% percent of trials that started reached the finish line to date. In the past 5 years, 35 clinical trials started and 32 clinical trials were completed. i.e. 91.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Woodland International Research Group" #1 sponsor was "Sunovion" with 20 trials, followed by "Otsuka Pharmaceutical Development & Commercialization, Inc." with 8 trials sponsored, "Indivior Inc." with 7 trials sponsored, "Karuna Therapeutics" with 7 trials sponsored and "Naurex, Inc, an affiliate of Allergan plc" with 7 trials sponsored. Other sponsors include 42 different institutions and companies that sponsored additional 38 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Woodland International Research Group" #1 collaborator was "H. Lundbeck A/S" with 6 trials as a collaborator, "PRA Health Sciences" with 2 trials as a collaborator, "Celerion" with 1 trials as a collaborator, "Cognitive Research Corporation" with 1 trials as a collaborator and "Gedeon Richter Ltd." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Woodland International Research Group" are "Schizophrenia" (38 trials), "Depressive Disorder, Major" (8 trials), "Bipolar I Disorder" (6 trials), "Major Depressive Disorder" (6 trials) and "Bipolar Disorder" (3 trials). Many other conditions were trialed in "Woodland International Research Group" in a lesser frequency.

Most popular intervention types in "Woodland International Research Group" are "Drug" (90 trials), "Other" (7 trials), "Biological" (1 trials), "Combination Product" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (42 trials), "Xanomeline and Trospium Chloride Capsules" (7 trials), "Lurasidone" (6 trials), "Rapastinel" (6 trials) and "SEP-363856" (6 trials). Other intervention names were less common.

The vast majority of trials in "Woodland International Research Group" are 95 trials for "All" genders.

Currently, there are NaN active trials in "Woodland International Research Group". undefined are not yet recruiting, 16 are recruiting, 4 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 63 completed trials in Woodland International Research Group, undefined suspended trials, and 11 terminated clinical trials to date.

Out of the total trials that were conducted in Woodland International Research Group, 15 "Phase 1" clinical trials were conducted, 19 "Phase 2" clinical trials and 59 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 2 trials that are defined as “Not Applicable".